Catalyst
Slingshot members are tracking this event:
Intercept Pharmaceuticals (ICPT) plans to commence Phase 3 obeticholic acid (OCA) cirrhosis trial in the second half of 2017
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| ICPT | Community voting in process | |||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Feb 12, 2018
Occurred Source:
http://ir.interceptpharma.com/news-releases/news-release-details/intercept-announces-phase-3-reverse-trial-evaluating-oca
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Obeticholic Acid, Cirrhosis, Phase 3
